Pyxis Oncology, Inc.PYXSNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank40
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-57.67M
↓ 30% vs avg
Percentile
P40
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-44.23M
Historical baseline
PeriodValueYoY Change
2024$-57.67M+18.4%
2023$-70.71M+20.8%
2022$-89.33M-152.9%
2021$-35.33M-250.3%
2020$-10.08M-350.4%
2019$-2.24M-